Skip to main content
. 2022 May 17;13:823826. doi: 10.3389/fpsyt.2022.823826

TABLE 1.

Demographics data of the study.

Age (year) M (SD) 45.7 (15.2)
Gender (M/F) 924/1103
CPZeq (mg/day) M (SD) 683.5 (449.1)
Antipsychotic polypharmacy rate (%) 44.1
BPeq (mg/day) M (SD) 0.8 (1.5)
Anticholinergics prescription rate (%) 30.5
Antidepression prescription rate (%) 8.5
Mood stabilizers or anticonvulsants prescription rate (%) 35.6

CPZeq, chlorpromazine equivalent; BPeq, biperiden equivalent; M, mean, SD, standard deviation.